Endothelial repair in stented arteries is accelerated by inhibition of Rho-associated protein kinase by Hsiao, S.T. (Sarah T.) et al.
Endothelial repair in stented arteries is
accelerated by inhibition of Rho-associated
protein kinase
Sarah T. Hsiao1,2, Tim Spencer3, Luke Boldock4,2, Svenja Dannewitz Prosseda1,2,
Ioannis Xanthis1,2, Francesco J. Tovar-Lopez5, Heleen M. M. Van Beusekom6,
Ramzi Y Khamis7, Nicolas Foin8, Neil Bowden1,2, Adil Hussain1,2, Alex Rothman1,2,
Victoria Ridger1,2, Ian Halliday3, Cecile Perrault4,2, Julian Gunn1,2, and
Paul C. Evans1,2,9*
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK; 2INSIGNEO Institute of In Silico Medicine, University of Sheffield,
Sheffield S10 2RX, UK; 3Materials and Engineering Research Institute, Sheffield Hallam University, Sheffield S1 4RF, UK; 4Department of Mechanical Engineering, University of Sheffield,
Sheffield S10 2RX, UK; 5School of Electrical and Computer Engineering, RMIT University, Melbourne VIC 3001, Australia; 6Department of Cardiology, ERASMUS MC, Rotterdam 3015
CE, the Netherlands; 7Faculty of Medicine, National Heart and Lung Institute, Imperial College London WI2 0HS, UK; 8National Heart Centre, Singapore 169609; and 9Bateson Centre,
University of Sheffield, Sheffield S10 2RX, UK
Received 31 March 2016; revised 9 September 2016; accepted 17 September 2016; online publish-ahead-of-print 26 September 2016
Time of primary review: 42 days
Aims Stent deployment causes endothelial cells (EC) denudation, which promotes in-stent restenosis and thrombosis.
Thus endothelial regrowth in stented arteries is an important therapeutic goal. Stent struts modify local hemody-
namics, however the effects of flow perturbation on EC injury and repair are incompletely understood. By studying
the effects of stent struts on flow and EC migration, we identified an intervention that promotes endothelial repair
in stented arteries.
....................................................................................................................................................................................................
Methods
and Results
In vitro and in vivo models were developed to monitor endothelialization under flow and the influence of stent
struts. A 2D parallel-plate flow chamber with 100 lm ridges arranged perpendicular to the flow was used. Live cell
imaging coupled to computational fluid dynamic simulations revealed that EC migrate in the direction of flow
upstream from the ridges but subsequently accumulate downstream from ridges at sites of bidirectional flow. The
mechanism of EC trapping by bidirectional flow involved reduced migratory polarity associated with altered actin
dynamics. Inhibition of Rho-associated protein kinase (ROCK) enhanced endothelialization of ridged surfaces by
promoting migratory polarity under bidirectional flow (P< 0.01). To more closely mimic the in vivo situation, we
cultured EC on the inner surface of polydimethylsiloxane tubing containing Coroflex Blue stents (65lm struts) and
monitored migration. ROCK inhibition significantly enhanced EC accumulation downstream from struts under flow
(P< 0.05). We investigated the effects of ROCK inhibition on re-endothelialization in vivo using a porcine model of
EC denudation and stent placement. En face staining and confocal microscopy revealed that inhibition of ROCK
using fasudil (30mg/day via osmotic minipump) significantly increased re-endothelialization of stented carotid
arteries (P< 0.05).
....................................................................................................................................................................................................
Conclusions Stent struts delay endothelial repair by generating localized bidirectional flow which traps migrating EC. ROCK
inhibitors accelerate endothelial repair of stented arteries by enhancing EC polarity and migration through regions
of bidirectional flow.
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1. Introduction
Interventions used routinely to treat arterial disease, including balloon
angioplasty and stent implantation, lead to damage and loss of endothe-
lial cells (EC). Given the essential role of EC in suppressing inflammation
and thrombosis, the restoration of functional vascular endothelium is an
important therapeutic goal to avoid the lethal consequences of in-stent
restenosis and thrombosis.1,2 There are several factors that can poten-
tially influence re-endothelialization in stented arteries, one of which is
the presence of the stent itself that provides a non-physiological surface
for cell adhesion and alters blood flow.3–5 However, the effect of stent
deployment on EC repair remains poorly understood. This issue is par-
ticularly relevant in the era of drug-eluting stents, which release cyto-
static compounds to prevent restenosis. They are coated with sirolimus
(Cypher) that targets the mammalian target of rapamycin pathway or
paclitaxel (Taxus) that targets microtubules to suppress cell motility and
mitosis. Although drug-eluting stents have effectively reduced rates of
restenosis, they have also been associated with a higher incidence of late
and very late thrombosis.1,2,6 These deleterious effects have been attrib-
uted, in part, to the effects of cytostatic compounds on vascular endo-
thelium leading to delayed healing and subsequent exposure of stent
struts for thrombus initiation.6–8 There is therefore a need to develop
new strategies to accelerate endothelialization of stented arteries and
thereby reduce the incidence of late and very late thrombosis.
The repair of injured vascular endothelium involves migration of EC
from adjacent uninjured sites.8,9 Cell migration is a tightly co-ordinated
process that requires the establishment of front–rear polarity. It involves
the formation of a membrane protrusion at the cell front via the poly-
merization of actin filaments.10 The subsequent development of adhe-
sions links the actin cytoskeleton to the extracellular matrix, thus
allowing the generation of traction forces via actomyosin contraction.
On the other hand, sustainedmigration requires the severing of actin fila-
ments at the rear of the cell for subsequent rounds of actin nucleation.
Rho-associated protein kinase (ROCK) controls the migration cascade
by promoting phosphorylation of actin-binding proteins including myosin
light chain (MLC) and cofilin which control actin dynamics, actomyosin
contractility and cell polarity.11–13
The deployment of a stent by balloon angioplasty leads to major
changes in vascular mechanics. Of note, the presence of stent struts alters
local blood flow patterns thereby modifying wall shear stress (WSS),3–5 a
frictional force that is exerted by flowing blood on the vessel wall.
Alterations in WSS induced by stent application have been correlated
with neointimal hyperplasia4 and we hypothesize that they may also influ-
ence the physiology of EC, which are exquisitely sensitive to flow.
Here we used in vitro and in vivomodels to study the influence of stent
struts on local hemodynamics and EC migration. Stent struts generated
disturbed flow patterns which reduced EC polarization and impeded
migration towards cell-free space. Inhibition of ROCK enhanced EC
migration over stent struts by promoting migratory polarization of cells
via modulating the activity of MLC and cofilin. We conclude that ROCK
inhibitors may have beneficial effects in stented arteries by promoting
re-endothelialization and thus restoring vascular homeostasis.
2. Methods
2.1 Study approval
For studies of human cells, experiments were approved by University of
Sheffield Research Ethics Committee (reference 10/H1308/25) and all
subjects gave informed consent. Studies using human cells were used in
accordance to the standards set by the Declaration of Helsinki. For animal
studies, all procedures were approved by the University of Sheffield ethics
committee and performed in accordance with the UK Home Office Animals
(Scientific Procedures) Act 1986 and in accordance with Directive 2010/63/
EU of the European Parliament on the protection of animals used for scien-
tific purposes.
2.2 EC culture and application of flow
Pharmacological inhibition of ROCK activity was performed using Y27632
(Calbiochem) or fasudil (5-(1,4-Diazepane-1-sulfonyl) isoquinoline; HA-
1077; Calbiochem) at 2 mM. Silencing of ROCK1 and ROCK2 was performed
using small interfering RNA (siRNA; ON-TARGETplus Human ROCK1
siRNA SMARTpool and ON-TARGETplus Human ROCK2 siRNA
SMARTpool). Human umbilical vein EC (HUVEC) were isolated using colla-
genase digestion. Human coronary artery EC (HCAEC) were obtained com-
mercially (PromoCell, Heidelberg, Germany). EC were seeded into
polydimethylsiloxane (PDMS) flow chambers with ridges (100 mm high, 100
mm length) or onto flat flow chambers (Ibidi fibronectin-coated m-Slide I0.6,
Ibidi GmbH). Flowing medium was applied using the Ibidi pump system and
chamber slides were placed on the stage of an inverted light microscope
(NikonVR TE300) enclosed in a Perspex box warmed to 37 C. Time-lapse
imaging was performed for up to 96h. Individual cells were manually tracked
using ImageJ software. 3D stented model vessels were fabricated with PDMS
and the internal surface was coated with fibronectin prior to deployment of a
Coroflex Blue stent. EC were seeded as a confluent monolayer upstream of
the first stent strut. Flowing medium was applied using the IbidiVR pump sys-
tem in a 5% CO2 humidified atmosphere at 37 C. EC were identified by light
microscopy. Multiple independent experiments were conducted using pri-
mary cells isolated from different individuals, and the number of independent
experiments carried out is stated in the figure legends.
2.3 Immunofluorescent staining of cultured EC
Cell polarity was assessed by immunofluorescent staining using antibodies
against b-tubulin (Cell Signalling Technology) and Alexafluor568-conjugated
secondary antibodies (Invitrogen) to identify the microtubular organizing
centre (MTOC), phalloidin-488 (Cell Signalling Technology) to identify actin.
Nuclei were identified using DAPI (Sigma). Imaging was carried out using an
inverted fluorescence microscope (Olympus IX71) and image analysis was
performed using Image J software (1.49p). Polarized cells were defined as
those with an elongated morphology with the MTOC positioned upstream
from the nucleus as described.13
2.4 Western blotting and enzyme-linked
immunosorbent assay
Total cell lysates were isolated using lysis buffer (Tris 25mM, sodium chloride
150mM, 0.1% Sodium dodecyl sulphate, 0.5% sodium deoxycholate, 1%
Triton X100). Western blotting was carried out using specific antibodies
against phosphorylated cofilin (Cell Signalling Technology), phosphorylated
MLC (Cell Signalling Technology), and pyruvate dehydrogenase complex
component X (PDHX; Cell Signalling Technology) with horse radish
peroxidase-conjugated secondary antibodies (Dako). Chemiluminescent
detection was carried out using ECL PrimeVR (GE Healthcare). The protein
levels of tissue factor pathway inhibitor (TFPI) or von Willebrand factor
(vWF) in cell lysates or cell culture supernatants were quantified by enzyme-
linked immunosorbent assay (ELISA; AbCam).
2.5. In vivo porcine stent model
Male Yorkshire White pigs (22–27kg) were studied. EC denudation of caro-
tid arteries was achieved by inflating a balloon 5 times for 30 s at a balloon/
artery diameter ratio of 1.2:1. A CoroflexTM stent was deployed over the
denuded region. Animals were then treated with fasudil (30mg/day) or with
vehicle alone using osmotic minipumps. Aspirin (150mg/day) and clopidogrel
690 S.T. Hsiao et al.
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(75mg/day) were given orally for 3 days following stent implantation. After 3
days, EC coverage of the stented segment was determined by en face staining
using anti-PECAM-1 antibodies followed by confocal microscopy.
2.6 Computational fluid dynamics
Fluid flow in the 2D (3D) chamber was studied using the two-dimensional
[D2Q9 (D3Q19)] two-relaxation-time (TRT) incompressible lattice
Boltzmann (LB) method14,15 to solve the isothermal incompressible Navier-
Stokes and Continuity equations. A TRTmagic parameter15 of 3/16 was used
and the inlet (outlet) parabolic-velocity (constant-pressure) was fixed whilst
the inlet (outlet) pressure (velocity) were linearly extrapolated. LB node
spacing was 10/3lm with an upstream (downstream) free region of 2mm
(2.6mm) to avoid entrance (exit) disturbances. WSS values were obtained
from quadratic extrapolations from near wall sites. The fluid was taken as
Newtonian water (shear viscosity, g¼ 103 Pa.s, density, q¼ 103 kg/m3) and
steady flow simulations were carried out at Reynolds numbers, Re ¼ UmaxHqg
¼ 117 corresponding to an open channel WSS values of 13dyn/cm2 respec-
tively (H¼ 600lm, Umax¼maximum inlet velocity). Studies of fluid flow in
stented PDMS tubes or arteries required import of cross-sectional lumen sli-
ces from lCT analysis to CFD analysis using the marker-cell method with
matched voxel resolution (Re ¼ UDhq=g where U¼mean velocity and
Dh¼mean diameter). For stented PDMS tubes, WSS measurements
were extrapolated as for the 2D system and taken from steady state flow
Re¼ 410 with the Newtonian viscosity taken as that of culture medium
(g¼ 7.3104 Pa.s, q ¼ 1005kg/m3). For stented carotid arteries, Re¼ 150
with the Newtonian viscosity taken as blood (g¼ 3.7103 Pa.s, q ¼ 1060
kg/m3).
2.7 Statistical analysis
All experiments were performed at least three times and data are presented
as mean6 standard error mean. Statistical significance was determined using
either Student’s t-test or one-way ANOVA followed by a Bonferroni multiple
comparison post hoc test when appropriate using the Prism6 software.
A P value of less than 0.05 was considered to be statistically significant.
3. Results
3.1 A 2D in vitro model of EC migration
over stent strut geometries
To study the influence of stent strut geometries on flow patterns and
consequent effects on EC migration, we developed an in vitro flow cham-
ber that contained three ridges that were 100 mm high and 100 mmwide
and separated by 400 mm (approximating the geometry of second gener-
ation stent struts). The chamber was linked to a continuous-pump flow
system with ridges positioned perpendicular to the flow direction
(Figure 1A) and coupled to a live cell imaging platform. CFD demon-
strated that cell culture medium introduced at a flow rate of 21.6ml/min
would generate flow velocities that were highest through the centre
(0.25 m/s) and decreased in magnitude when approaching the top and
bottom of the chamber (Figure 1B top). The pressure along the length of
the parallel plates was mostly homogeneous with a gradual 5% decrease,
while the presence of ridges generated variation in the pressure gradient
around these features (Figure 1B bottom). Mapping the WSS revealed
that it was relatively high (13 dyn/cm2) and unidirectional at the inlet,
whereas areas immediately upstream and downstream from the ridges
were exposed to a low time-averaged WSS values, correlating with
recirculating flow patterns observed in the flow path analysis (Figure 1C).
In detail, WSS was reduced to 0 dyn/cm2 just upstream of the ridge, fol-
lowed by a sharp increase in WSS along the first vertical plane of the
ridge (blue) that peaked at> 100 dyn/cm2 at the interface between
vertical and horizontal planes of the ridge (Figure 1D). The WSS
remained elevated (30 dyn/cm2) on top of the ridge (red), decreased
sharply along the second vertical plane of the ridge (blue) and remained
low in the flow recirculation zone downstream from the ridge. The pat-
tern of WSS variation repeated for each of the ridges. The disruption in
flow was confirmed by particle imaging velocimetry which revealed that
the accumulation of polystyrene beads was greater downstream from
the ridge (4076 35 beads per mm2) where a large recirculating zone
was present, compared to a site immediately upstream (proximal;
1956 30 beads per mm2) or further upstream (distal; 1236 16 beads
per mm2) from the ridge (Figure 1E and F). Overall, these data indicate
that the ridges alter high unidirectional flow (at the inlet) to create local
flow disturbances including a region of very high unidirectional WSS at
the top of the ridge and recirculating bidirectional flow with low-average
WSS downstream from the ridge (herein referred to as bidirectional
flow).
3.2 EC migration was impeded at sites of
bidirectional flow located downstream
from ridges
To determine the effect of ridges on ECmigration, HUVECwere seeded
onto the ridged flow chamber (between the inlet and the first ridge) or
onto a flat surface as a control. Flow was applied to the chamber and EC
migration monitored by live cell imaging. Cells migrated over the flat sur-
face in the direction of flow and covered a distance of> 500 mm in 24h
(Figure 2A top and Supplementary material online, Movie 1). Cells on the
ridged slide negotiated the first ridge (despite the elevated WSS at the
upper surface) and reached the region downstream of the ridge effec-
tively (Figure 2A bottom and Supplementary material online, Movie 2).
However, EC did not migrate beyond the region of bidirectional flow
located downstream from the ridges (Figure 2A compare top with bottom
and Supplementary material online,Movie 2).
These features were assessed by single cell tracking which revealed
unified forward migration in the flow direction in cells exposed to unidir-
ectional flow (Figure 2B left), but less uniform direction in cells under
bidirectional flow (Figure 2B right). This was quantified by measuring the
angle between the radial axis (joining the origin and final position of the
cell) and the flow axis (nominated 0), which was wider in cells exposed
to bidirectional compared to unidirectional flow (Figure 2C and D). The
directional persistence, which is a ratio of the Euclidean distance: accu-
mulated contour distance travelled and therefore a measure of the uni-
formity of migration direction, was also significantly reduced in cells
exposed to bidirectional compared to unidirectional flow (Figure 2E). In
addition to the loss of directionality in HUVEC under bidirectional flow,
the average velocity (0.786 0.10 mm/min) was also significantly reduced
compared to cells under unidirectional flow (1.136 0.09 mm/min;
Figure 2F). These data indicate that the direction and velocity of HUVEC
migration were impeded downstream from the ridge. Thus we propose
that EC in the upstream region move into free space effectively because
their migration is promoted by unidirectional flow, whereas EC in the
downstream region become ‘trapped’ because bidirectional flow at that
site exerts opposing directional cues.
3.3 ROCK inhibitors enhance EC migration
under bidirectional flow
Wehypothesized that interventions that uncouple EC from flow-mediated
directional cues may allow EC to migrate from regions of bidirectional
flow into cell free space. This was tested using inhibitors of ROCK, a
Hsiao: accelerated endothelial repair with ROCK inhibitors 691
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Studies were carried out using HUVEC or HCAEC cultured on commer-
cial slides exposed to bidirectional flow (6 4dyn/cm2 at 0.1Hz) or unidir-
ectional flow (13dyn/cm2) as a control. It was observed that HUVEC
exposed to bidirectional flow exhibited delayed migration into cell-free
space (Figure 3A compare top and bottom panels, and compare
Supplementary material online, Movies 3 and 4), a greater deviation in
migration from the flow axis (Figure 3B, C, and Supplementary material
online, Figure S1A and B) and reduced velocity (Supplementary material
online, Figure S1C) compared to cells exposed to unidirectional flow.
Treatment with pharmacological ROCK inhibitors (Y27632 or fasu-
dil) promoted migration along the flow axis (Figure 3B, D, and E), and
significantly enhanced directional persistence (Figure 3F) in cells
exposed to bidirectional flow whereas there was no effect on migra-
tion velocity (Figure 3G). Similar observations were made using
HCAEC which exhibited a greater deviation in migration from the
flow axis, reduced directional persistence and reduced velocity com-
pared to cells exposed to unidirectional flow (Supplementary mate
rial online, Figure S2A–D). Inhibition of ROCK enhanced migration
along the flow axis and increased directional persistence without
A
B
C F
D
E
Figure 1 Fluid flow in the ridged chamber slide. (A) Configuration of the ridged flow chamber. (B–D) CFD were carried out to simulate flow patterns and
WSS magnitude assuming an inlet flow rate of 21.6ml/min. Flow is from left to right. (B) The average velocity (upper) and pressure gradient (lower) along
the chamber slide are shown. (C) The flow path (upper, cross-sectional) and time-averaged WSS map (lower, upper surface view) are shown. (D) The
unfoldedWSS map along the surface of the ridges. Grey-shaded area represents the vertical planes of the ridge and the red-shaded area represents the hori-
zontal plane of the ridge. (E and F) The ridged slide was exposed to flowing water and particle imaging velocimetry was performed. (E) Collated time-lapse
images of fluorescently labelled microspheres are shown. A total of seven images were merged and each image was represented with a different colour
(upper panel, upper surface view). Flow patterns predicted fromCFD are shown for reference (lower panel, cross-sectional). (F) Microspheres accumulating
at the upstream distal, upstream proximal, and downstream regions were quantified. Data were pooled from three independent experiments and mean val-
uesþ/ SEM are shown alongside individual data points. Differences between means were compared using a one-way ANOVA.
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(Supplementary material online, Figure S2E and G). Similar effects
were also generated by siRNA-mediated silencing of ROCK1/2
(Supplementary material online, Figure S3) which promoted HUVEC
migration along the flow axis (Figure 3H) and enhanced directional
persistence (Figure 3I) in cells exposed to bidirectional flow without
altering average velocity (Figure 3J). Thus inhibition of ROCK pro-
moted EC migration into cell-free space under bidirectional flow.
The effects of ROCK inhibition were also studied using EC exposed
to flow on ridged slides. EC treated with Y27632 migrated further
downstream from the ridge compared to controls (Figure 4A, compare
top and bottom panels) and were capable of crossing the second ridge
under ROCK inhibition (Supplementary material online, Movie 5).
Similarly, single cell tracking analysis demonstrated that ROCK inhibition
enhanced migration along the flow axis (Figure 4B–D), enhanced direc-
tional persistence (Figure 4E) and modestly heightened average migration
velocity (Figure 4F) in EC exposed to bidirectional flow downstream
from ridges. We conclude that ROCK inhibitors enhance endothelializa-
tion of ridged surfaces exposed to flow by promoting EC migration
through regions of bidirectional flow into cell-free space.
A
B C
D E F
Figure 2 The migration pattern of ECwas disrupted under bidirectional flow. HUVEC were seeded on flat or ridged slides (upstream from the first ridge)
and their migration under flow was monitored by time-lapse imaging for 72h. (A) Representative images. Flow at inlet is from left to right.White dotted lines
represent leading edge of monolayers. White bar¼ 100lm. (B–D) Single cell tracking analysis of cells exposed to unidirectional or bidirectional (down-
stream from ridge) flow. (B) Migration paths are shown. Flow at inlet is from left to right. Each red dot represents a cell. Yellow lines indicate a 15% deviation
from the inlet flow direction. (C and D) For each cell, the angle between its final position and the inlet flow direction (180) was calculated (angle deviation).
(C) Angle deviations were divided into 20 18 groups and the number of cells in each group is shown. (D) Angle deviations, (E) directional persistence and
(F) average velocities were calculated. Data were pooled from five independent experiments and mean valuesþ/ SEM are shown alongside individual data
points. Differences betweenmeans were compared using an unpaired t-test.
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Figure 3 ROCK inhibition enhanced ECmigration into cell-free space under bidirectional flow. (A) HUVECwere seeded onto Ibidi slides, exposed to uni-
directional or bidirectional flow andmigration was monitored. Representative images are shown. Flow at inlet is from left to right. White dotted lines repre-
sent leading edge of monolayers. White bar ¼ 100lm. (B–G) HUVEC were seeded onto Ibidi slides and exposed to unidirectional or bidirectional flow in
the presence of a ROCK inhibitor (2lM Y27632 or 2lM fasudil) or DMSO vehicle and migration was monitored. (B) Migration paths. Each red dot repre-
sents a cell. Yellow lines indicate a 15% deviation from the inlet flow direction. (C–E) For each cell, the angle between its final position and the inlet flow
direction (180) was calculated (angle deviation). (C and D) Angle deviations were divided into 20  18 groups and the number of cells in each group is
shown. (E) Angle deviations, (F) directional persistence (DP; contour distance/Euclidean distance) (G) and migration velocities were calculated. Data were
pooled from four independent experiments and mean values þ/ SEM are shown alongside individual data points. (H–J) EC were treated with siRNA
against ROCK1 and ROCK2 (siROCK1/2) or with non-targeting scrambled sequences, exposed to unidirectional or bidirectional flow and migration was
monitored. (H) Angle deviations, (I) directional persistence (DP), and (J) average velocities were calculated. Data were pooled from three independent
experiments and mean valuesþ/ SEM are shown alongside individual data points. Differences between means were compared using a one-way ANOVA
(E–G) or unpaired t-test (H–J).
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The underlying molecular mechanism was studied by assessing the
effects of shear stress and ROCK inhibition on the phosphorylation of
MLC and cofilin which are regulators of actin dynamics and cell polar-
ity.11–13 Western blotting revealed that the levels of phosphorylated
forms of MLC (activated by phosphorylation) and cofilin (inactivated)
were enhanced in EC exposed to bidirectional compared to unidirec-
tional flow (Figure 5A). Notably, pharmacological inhibition of ROCK
reduced the levels of phosphorylated MLC and cofilin in cells exposed to
bidirectional flow (Figure 5A), thus simultaneously reducing MLC activity
while enhancing cofilin activity. These changes led us to hypothesize that
ROCK inhibition may alter migratory polarity which is intimately linked
to actin dynamics. This was tested by immunofluorescent staining to
determine the relative positions of the nucleus, MTOC, and the actin
cytoskeleton. In polarized cells, the MTOC is positioned behind the
nucleus along the axis of elongation as described.13 It was observed that
the proportion of EC that displayed polarity was reduced in cultures
exposed to bidirectional compared to unidirectional flow, and that phar-
macological inhibition of ROCK significantly enhanced the polarization
of EC exposed to bidirectional flow (Figure 5B). Thus we conclude that
ROCK inhibition promotes EC polarity under bidirectional flow associ-
ated with altered actin dynamics.
We also examined whether ROCK inhibitors could influence the
expression of TFPI and vWF since these regulators of haemostasis are
known to be expressed in sheared endothelium.18 Using ELISA, it was
demonstrated that TFPI (Supplementary material online, Figure S4A) and
vWF (Supplementary material online, Figure S4B) levels in HCAEC
A
B
D E F
C
Figure 4 ROCK inhibition promoted EC migration on a ridged surface exposed to bidirectional flow. (A) HUVEC were seeded onto ridged slides
upstream from the first ridge, exposed to flow in the presence of a ROCK inhibitor (2lM Y27632) or DMSO control and migration was monitored.
(A) Representative images are shown. Flow at inlet is from left to right. White dotted lines represent leading edge of monolayers. White bar¼ 100lm.
(B) Migration paths. Each red dot represents a cell. Yellow lines indicate a 15% deviation from the inlet flow direction. (C and D) For each cell, the angle
between its final position and the inlet flow direction (180) was calculated (angle deviation). (C) Angle deviations were divided into 20  18 groups and
the number of cells in each group is shown. (D) Angle deviations, (E) directional persistence (DP; contour distance/Euclidean distance), and (F) migration
velocities were calculated. Data were pooled from four independent experiments and mean valuesþ/ SEM are shown alongside individual data points.
Differences betweenmeans were compared using an unpaired t-test.
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exposed to bidirectional flow were not significantly altered by applica-
tion of the ROCK inhibitor Y27632. Thus we conclude that ROCK inhib-
itors promote EC migration under disturbed flow without altering TFPI
or vWF expression.
3.4 ROCK inhibition enhanced
endothelialization of a 3D in vitro stent
model.
The ridged parallel-plate system that we developed is a highly reduction-
ist model of EC responses to stent struts. To more closely mimic the
in vivo situation, we determined the ability of EC to migrate over
Coroflex Blue stents (65 mm strut diameter) that were deployed in
PDMS tubing and subsequently exposed to flow. This 3D flow system is
advantageous because it allows assessment of EC responses to complex
stent geometries including flow dividers and acutely angled struts, the
effects of stent materials on endothelial physiology can be monitored,
and PDMS tubing is compliant thus providing a better approximation of
the vascular mechanical environment compared to an inflexible 2D
surface.
The influence of the flow was determined by CFD simulations using a
3D geometry generated via a PDMS cast followed by microCT imaging
A
B
Figure 5 ROCK inhibition enhanced endothelial polarity under bidirectional flow by modifying actin dynamics. (A) HCAEC were seeded onto Ibidi slides
and exposed to unidirectional or bidirectional flow in the presence or absence of a ROCK inhibitor (2lM Y27632) for 12 h. Total cell lysates were tested
byWestern blotting using antibodies that detect phosphorylated forms of cofilin (Ser 3) andMLC (Thr18/Ser19) or by using anti-PDHX antibodies to assess
total protein levels. Representative blots are shown. The levels of Phospho-Cofilin and Phospho-MLC were quantified by densitometric analysis. Data were
pooled from three independent experiments and mean valuesþ/ SEM are shown alongside individual data points. Differences between means were com-
pared using a one-way ANOVA. (B) HUVEC were seeded onto Ibidi slides and exposed to unidirectional or bidirectional flow in the presence or absence of
a ROCK inhibitor (2lM Y27632) for 4 h. Cell polarity was assessed by immunofluorescent staining of b-tubulin (red), co-staining of actin using Phalloidin-
488 (green) and co-staining of nuclei (DAPI; blue). Scale bar, 200lm. The proportion of polarized cells (elongated morphology with the MTOC positioned
upstream from the nucleus) was calculated. Data were pooled from three independent experiments andmean valuesþ/ SEM are shown alongside individ-
ual data points. Differences betweenmeans were compared using a one-way ANOVA.
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(Supplementary material online, Figure S5A). Similar to the 2D parallel-
plate system, WSS values are elevated (>40 dyn/cm2) on the ridges of
the struts with low values just downstream and upstream of the strut
(Supplementary material online, Figure S5B). Bidirectional recirculation
zones are restricted to strut orientations perpendicular to the flow
direction and lead to complex streamlines lines (Supplementary material
online, Figure S5C). For example, the flow path labelled ‘a’ in
Supplementary material online, Figure S5B is associated with an average
WSS value of 15 dyn/cm2 against the tubing walls. However, WSS is
reduced to 0 dyn/cm2 just upstream of a ridge, followed by a sharp peak
in WSS along the vertical plane peaking at> 50dyn/cm2 at the interface
between the vertical and horizontal planes (plotted in Supplementary
material online, Figure S5D). WSS remains elevated along the ridge top,
then decreases sharply along the downstream vertical plane. This pattern
inWSS is repeated for each strut orientation.
We hypothesized that inhibition of ROCKwill increase endothelializa-
tion of stented PDMS tubes. Thus Coroflex Blue stents were deployed
in fibronectin-coated PDMS tubing under sterile conditions. HUVEC
were then seeded immediately upstream from the first stent strut prior
to the application of flow and subsequent assessment of EC coverage by
brightfield microscopy. The study revealed that the application of a
ROCK inhibitor (Y27632) significantly enhanced the number of cells that
accumulated downstream from the first strut at 24 h (Figure 6A and B,
upper panel) and downstream from both the first and second struts at
42 h (Figure 6B, lower panel). We conclude that inhibition of ROCK
enhanced endothelialization of stents exposed to flow under in vitro
experimental conditions.
3.5 ROCK inhibition enhanced
re-endothelialization of stented arteries
in vivo
Next we investigated whether inhibition of ROCK can promote re-
endothelialization of stented arteries in vivo. This study required the abil-
ity to deploy a stent over a denuded arterial segment under well-
controlled experimental conditions. The porcine left carotid artery was
selected for study because the geometry of this vessel is relatively uni-
form, allowing precise catheter-based intervention. Quantitative angiog-
raphy was used to guide balloon angioplasty and subsequent stent
placement over the injured segment (Supplementary material online,
Figure S6). The influence of balloon angioplasty on endothelial coverage
was assessed by en face staining using anti-PECAM-1 antibodies followed
by confocal microscopy. It demonstrated that inflation of a balloon to
approximately 1.2 times the artery diameter created vascular injury with
loss of endothelial coverage and exposure of underlying smooth muscle
cells, whereas intact endothelial monolayers were present in uninjured
arteries (Figure 7A). Thus angioplasty and stent placement in the left por-
cine carotid artery represent a useful model to study the processes that
govern EC denudation and repair.
The influence of stent deployment on WSS was determined by CFD
using a geometry generated by microCT imaging of a PDMS cast
(Figure 7B). Time-average calculations revealed a maximum velocity
occurred at the centre of the lumen (0.28 m/s) with decreasing magni-
tude approaching the lumen surfaces. Mapping the WSS showed unidir-
ectional highest values located upstream and downstream from the
stent due to the smaller cross-sectional area at these sites (Figure 7C,
upper panel). In the stented segment, WSS was approximately 15dyne/
cm2 at the inter-strut regions and the highest values (>80 dyne/cm2)
were at the surface of the struts. Of particular note, sites downstream
from the struts were associated with low WSS and recirculating flow
(Figure 7C compare WSS (upper panel) and streamlines (lower panel) at
downstream and inter-strut sites). Our observation that stent placement
in carotid arteries generated recirculating flow led us to hypothesize that
A
B
Figure 6 ROCK inhibition enhanced the endothelialization of a 3D
in vitro stent model. An in vitro model of EC migration over stents was
established by deploying Coroflex Blue stents in PDMS tubing (1.5mm
diameter). HUVEC were seeded into PDMS tubes immediately
upstream from the stent. After 24h, flow was applied (27.35ml/min) in
the presence or absence of a ROCK inhibitor (2lM Y27632). EC cov-
erage was assessed by brightfield microscopy at 24h and 42h. (A)
Representative images are shown following 24h exposure to flow.
Individual EC are marked with a red dot to facilitate visualization. Note
that EC accumulation downstream from the first strut is greater in
Y27632-treated cultures compared to controls. (B) EC were counted
at the regions located downstream from the first or second struts (and
at the pre-strut region as a control). Data were pooled from three inde-
pendent experiments. Mean valuesþ/ SEM are shown alongside indi-
vidual data points. Differences between means were analysed by two-
way ANOVAwith Sidak’s post-tests.
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.. inhibition of ROCK may promote endothelialization in vivo. To investi-
gate this, we used fasudil to inhibit ROCK in vivo as it is tolerated well in
pigs as well as humans.19 Following angioplasty and stent placement in
the left carotid artery, animals were treated with fasudil (30mg/day)
using an osmotic minipump or with saline as a control. LC-MS detected
fasudil plasma concentrations of 93.16 49.1 ng/mL in the experimental
group, whereas the compound was not detected in saline-treated ani-
mals. En face staining using anti-PECAM-1 antibodies demonstrated that
the percentage of EC coverage was 58.86 11.0% in the saline-treated
control group at 3 days post-stent implantation, whilst intravenous deliv-
ery of fasudil resulted in significantly increased endothelialization of the
stent (90.26 3.1%; Figure 7D). We conclude that inhibition of ROCK
using fasudil significantly enhanced re-endothelialization of stented
arteries in vivo.
4. Discussion
4.1 Strategies to enhance
endothelialization of stented arteries
Endothelial loss during angioplasty and stent insertion is a major contrib-
utor to subsequent restenosis and thrombosis. Although EC repair can
occur naturally, the process is gradual and may be incomplete in some
situations, for example following insertion of drug-eluting stents.1,2,6 The
corollary is that interventions to accelerate EC repair may enhance func-
tion and reduce thrombosis risk in stented arteries. Migration of local EC
plays a role in re-endothelialization of injured vessels.8,9 For example,
studies of common carotid artery allografts between transgenic mice
with fluorescent endothelium (Tie2-GFP) and wild-type mice suggested
that regeneration of the endothelium involved local but not bone
marrow-derived EC.9 Similarly, a cell tracking study using mice that
received either aortic or bone marrow grafts from transgenic mice with
labelled EC (Tie2-LacZ) revealed that repair of the stented aorta
involved both locally derived and bone marrow-derived EC, although
the contribution of the latter varied between animals.8 Bone marrow-
derived cells contribute to repair in other models including vein grafts,20
A
B
C
D
Figure 7 ROCK inhibition promoted re-endothelialization of stented
arteries. (A–C) Endothelial injury in the left carotid artery was induced
via repeated balloon angioplasty. A CoroflexTM stent was then
deployed at the injured site. (A) En face staining of CD31 (green) and
nuclei (To-Pro; purple) revealed an intact endothelial monolayer (left)
in healthy arteries and loss of endothelium (dotted white lines) after
balloon angioplasty (right). Data shown are representative of those
obtained from n¼5 animals in three independent experiments. (B and
C) The influence on fluid dynamics was assessed. (B) A PDMS-based
cast of the lumen of a stented carotid artery (left) and lCT (right) was
performed to obtain a detailed geometry. (C) CFD predictions. Flow is
Figure 7 Continued
from left to right. Upper panel shows WSS in the entire stented
segment. Lower panel shows streamlines (white lines) for stent
struts in relation toWSS in detail. Note highWSS at struts and low
WSS corresponding to sites of recirculation downstream from
struts. (D) The influence of fasudil on EC repair in stented arteries
was determined using male Yorkshire White pigs. A portion of the
carotid artery was denuded by balloon angioplasty prior to implan-
tation of a CoroflexTM stent. Animals were treated using an
osmotic pump containing either saline (vehicle group; n ¼ 5 group
size) or fasudil (n ¼ 5 group size; 30mg/day) for 3 days. EC cover-
age of the stented segment was determined by en face staining for
CD31 followed by confocal microscopy. Representative images are
shown with stent struts depicted with a broken white line (upper
panels; scale bar¼100lm). The percentage of EC coverage over
stent struts was calculated for n ¼ 5 animals per group. Data were
pooled and mean values þ/ SEM are presented with individual
data points (lower panel). Differences between means were ana-
lysed using an unpaired t-test.
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..however their role is incompletely understood. Because of these consid-
erations, several groups have attempted to promote re-
endothelialization using stents that deliver growth factors21 or devices
that promote capture of circulating EC precursors.22 However, these
approaches have had either partial or negligible effects on in-stent reste-
nosis and thrombosis,22 possibly because they led to incomplete endo-
thelialization and/or because the restored EC layer was dysfunctional.
Thus new strategies are required to promote endothelialization of
stented arteries including novel surface chemistries23,24 and compounds
that enhance migration of EC to the stented segment.
4.2 Hemodynamic regulation of stent
endothelialization
Here we used in vitro reductionist models to determine the influence of
stent-induced changes in WSS on EC migration. Using a 2D parallel-
plate system, it was observed that EC migrated in the direction of flow
and were able to migrate over a 100lm-high ridge that was exposed to
very high WSS (> 100dyn/cm2). However, EC positioned downstream
from the ridge in a region exposed to flow recirculation migrated with
non-uniform direction and did not move effectively into free space. The
observation compliments data generated using a step-flow chamber,
where EC migration distance was decreased within the flow recircula-
tion zone.25 Thus EC migrate with uniform direction when they sense
unidirectional mechanical cues, but migrate less efficiently when they
sense bidirectional flow cues (Figure 8). The 2D in vitro model contained
ridges that were 100lm high and thus approximated the dimensions of
some stent struts used clinically. With the advancement in stent fabrica-
tion, stent strut size has reduced within the last decade and recent
designs are approximately 60lm in diameter.26 However, bioresorbable
scaffolds have considerably thicker strut sizes.27,28 Since thicker stent
struts are associated with increased risk of complications such as throm-
bogenicity,29 the influence of stent strut geometry on local hemodynam-
ics and EC repair remains an important consideration in stent design.
Although the 2D system provided important insight into the effects of
ridges on EC migration under flow, it did not capture more subtle
aspects of stent geometry (e.g. rounded edges, acute strut angles) that
can influence ECmigration by perturbing flow. Moreover, the 2D system
did not allow assessment of the effects of stent materials on EC behav-
iour. Because of these considerations, we developed an alternative
in vitro model where stents were placed in fibronectin-coated tubing
prior to seeding with EC and exposure to flow. This 3D system was
used to validate observations made using the 2D parallel-plate chamber
under with real stent geometries and materials under well-controlled
experimental conditions.
4.3 Inhibition of ROCK promoted EC
polarization and migration under
disturbed flow
The 2D and 3D in vitro systems that we have developed represent useful
platforms to test EC behaviour in response to different stent geometries,
materials, or pharmacological agents. Here we used them to identify a
novel pharmacological intervention, i.e. inhibition of ROCK, which pro-
moted ECmigration at sites of bidirectional flow by enhancing front-rear
polarization. The ROCK family consists of two isoforms, ROCK1 and
ROCK2, that act downstream from the small GTPase Ras homolog gene
family member A (RhoA) to regulate cell polarity and migration by alter-
ing actin cytoskeletal organisation and dynamics.10–12 Of particular rele-
vance, ROCK controls the direction of migration in EC exposed to
flow.17,18 Using both pharmacological agents and a gene silencing
approach, we examined the effects of ROCK inhibition on EC migration
under flow. It was noted using either a ridged chamber or Ibidi system
that ROCK inhibition enhanced EC migration under bidirectional flow
by causing cells to migrate straighter (enhanced directional persistence)
towards free-space. However, we also noted differences in EC behav-
iour between these systems. For example, inhibition of ROCK enhanced
EC migration velocity by approximately 20% in ridged slides but did not
in the parallel-plate system. It is likely that this relates to differences in
the mechanical environment generated by these systems since EC are
Figure 8 Schematic summary: ROCK inhibition promotes stent endothelialization by enhancing polarization and migration. A model is proposed. EC
migrate from adjacent sites to denuded portions of stented vessels. In the absence of ROCK inhibitor, EC polarization and migration at the region upstream
of stent struts are reinforced by flowwhich exerts a forward directional cue, whereas ECmigration downstream from struts is reduced by bidirectional flow
which reduces polarization. Thus EC become ‘trapped’ at the downstream bidirectional flow site. Inhibition of ROCK promotes EC polarization and there-
fore promotes their migration through sites of disturbed flow in stented arteries.
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exquisitely sensitive to relatively small changes in shear direction or mag-
nitude. Since the effects of ROCK inhibition on migration velocity were
relatively modest and restricted to a single in vitro system and not
reported by others,17,18 we propose that ROCK inhibition promotes
endothelialization of ridged surfaces under flow predominantly by reduc-
ing changes in the direction of migrating EC.
Live cell imaging studies revealed that ROCK inhibitors suppressed
ECmechanotaxis by uncoupling the direction of migration frommechan-
ical cues, whilst retaining kenotaxis which describes the capacity of cells
to move into free space (Figure 8). At a molecular level, the mechanism
was shown to involve changes in migratory polarity and altered activity
of MLC and cofilin. It was observed that EC exposed to bidirectional
flow displayed reduced polarity associated with increased MLC activity
compared to cells under unidirectional flow. Although MLC is required
for the formation of a single protrusion in migrating cells, highMLC phos-
phorylation leads to the induction of multiple protrusions and stable
adhesion thereby reducing polarized migration.11,12 We therefore pro-
pose that bidirectional flow induces excessive MLC activity which pre-
vents the establishment of migratory polarity thus impeding EC
migration into free space. Notably, ROCK inhibition counteracted the
effects of bidirectional flow by reducing MLC phosphorylation, thereby
enhancing polarization and migration.
MLC phosphorylation is positively regulated by MLC kinase as well as
ROCK.11,16 However, previous reports demonstrated that migratory
polarity can be enhanced by inhibition of ROCK but not by inhibition of
MLC kinase.11,16 Similarly, we found that pharmacological inhibition of
MLC kinase using ML7 did not enhance migration of HUVEC exposed to
bidirectional flow (data not shown). Thus although ROCK inhibition
enhanced EC migration under bidirectional flow via a mechanism that
involved MLC inactivation, the inhibition of MLC activity per se was not
sufficient to alter migration. This implies that ROCK inhibition enhances
migration by targeting other proteins besides MLC. A candidate target is
cofilin which is required for migratory polarity in multiple cell types.12,30
Moreover we observed that cofilin was inactivated via phosphorylation
in response to bidirectional flow and that inhibition of ROCK normalized
cofilin activity. Thus ROCK inhibitors promote EC migration through
bidirectional flow towards free space by simultaneously enhancing the
activity of cofilin and preventing excessive activation of MLC to enhance
migratory polarization. It should be noted that complete inhibition of
ROCK prevents cellular migration because ROCK is required for actino-
myosin contractility.31,32 Consistent with this, we observed that com-
plete silencing of ROCK1/2 using high doses of siRNA prevented EC
migration (data not shown) whereas partial silencing using lower doses
enhanced migration under bidirectional flow (Figure 3). Thus we propose
that partial inhibition of ROCK enhances migratory polarity of EC under
disturbed flow by altering the activity of MLC and cofilin, whilst retaining
sufficient actinomyosin activity for the generation of traction forces.
While we have focused on shear forces, a recent study by Canver et
al33 revealed that collective ECmigration is also tightly coupled tomatrix
stiffness. Stiff matrices generated high traction forces that reduced junc-
tional integrity, whereas matrices of intermediate stiffness better sup-
ported collective cell migration because intercellular junctions remained
intact. Interestingly, inhibition of ROCK promoted ECmigration distance
on soft substrates and increased directional persistence on both soft and
stiff substrates. Thus it will be of interest in future studies to examine the
functional interplay between shear stress and substrate stiffness in regu-
lating ROCK activity and its downstream effects on EC migration. This
has relevance to endothelialization of stented arteries since this interven-
tionmodifies vascular wall stiffness as well as shear stress.
4.4 Inhibition of ROCK enhanced stent
endothelialization
In order to test the effect of ROCK inhibition on vascular repair in a
stented artery in vivo, endothelial injury was performed via balloon angio-
plasty prior to stent deployment. We chose to study the carotid artery
because it has a relatively straight anatomy with minimal movement
throughout a cardiac cycle, thus allowing accurate positioning of balloon
injury and subsequent stent deployment via angiography. It was observed
using this model that systemic administration of the ROCK inhibitor fasu-
dil significantly enhanced re-endothelialization of stented carotid arteries.
This observation compliments a previous study demonstrating that sys-
temic administration of fasudil reduced neointimal formation in stented
porcine coronary arteries by promoting vascular smooth muscle cell
apoptosis and reducing inflammation.19 Although the latter study did not
report an effect of fasudil on endothelial coverage this could be because
early time points were not tested. Taken together, these and our obser-
vations indicate that inhibition of ROCK may be beneficial in the context
of stenting by enhancing re-endothelialization and by simultaneously
reducing vascular smooth muscle cell accumulation and restenosis. It is
notable that the beneficial effects of fasudil on endothelialization contrast
with the deleterious effects of sirolimus- and paclitaxel-eluting stents
which impede endothelial healing and have been associated with late
thrombosis.1,2,6,7 In clinical studies, fasudil reduced the occurrence of
cerebral vasospasm in patients with subarachnoid haemorrhage34 and
had beneficial effects in patients with stable angina.35 Thus fasudil could
be a candidate for repurposing to prevent restenosis and accelerate heal-
ing of vascular endothelium after angioplasty and stent placement.
Further work should now be carried out to determine whether local
delivery of fasudil or other ROCK inhibitors (via a drug-eluting stent or
balloon, for example) can enhance endothelial repair and protect against
restenosis in coronary arteries, and to compare its effectiveness with
sirolimus- and paclitaxel-eluting stents.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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